Eko Health, a San Francisco-based health-tech firm, raised $41M in Series D funding for AI-powered cardiac and pulmonary disease detection.

Investors ARTIS Ventures, Highland Capital Partners, and NTTVC led the round, with participation from Questa Capital, Double Point Ventures, EDBI, and LG Technology Ventures.

The funds will bolster U.S. market presence and accelerate global expansion, enhancing access to Eko's advanced health monitoring platform.

Eko Health, led by CEO Connor Landgraf, empowers healthcare professionals with digital stethoscopes and AI-driven analytics to improve disease detection and patient care.